Artificial Cells, Blood Substitutes, and Biotechnology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis
Volume 50, Issue 1, December 2022, Page 301-309 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 11, 2022 Category: Biotechnology Authors: Ze Mi Yunshu Zhang Zhichao Feng Jiahao Liu Jianmin Wu Hongpei Tan Xiaoqian Ma Zhenguo Liu Pengfei Rong Source Type: research

In vitro antiplasmodial activity, hemocompatibility and temporal stability of Azadirachta indica silver nanoparticles
Volume 50, Issue 1, December 2022, Page 286-300 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 10, 2022 Category: Biotechnology Authors: Joseph Hawadak Loick Pradel Kojom Foko Veena Pande Vineeta Singh Source Type: research

Enhanced anti-cancer effect using MMP-responsive L-asparaginase fused with cell-penetrating 30Kc19 protein
Volume 50, Issue 1, December 2022, Page 278-285 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 3, 2022 Category: Biotechnology Authors: Jina Ryu Sung Jae Yang Boram Son Haein Lee Jongmin Lee Jinmyoung Joo Hee Ho Park Tai Hyun Park Source Type: research

Green synthesis of gold nanoparticles using plant products and plants extracts aiming for cancer therapy: helping the beauty to beat ‘cure’ the beast
Volume 50, Issue 1, December 2022, Page 275-277 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 3, 2022 Category: Biotechnology Authors: Rania M. Hathout Source Type: research

Biogenic synthesis of CuO-NPs as nanotherapeutics approaches to overcome multidrug-resistant Staphylococcus aureus (MDRSA)
Volume 50, Issue 1, December 2022, Page 260-274 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 3, 2022 Category: Biotechnology Authors: Gamal M. El-Sherbiny Mohamed H. Kalaba Mohammed H. Sharaf Saad A. Moghannem Ahmed A. Radwan Ahmed A. Askar Mahmoud K. A. Ismail Ahmad S. El-Hawary Mahmoud A. Abushiba Source Type: research

The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 and replenish blood supply
Volume 50, Issue 1, December 2022, Page 240-251 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 3, 2022 Category: Biotechnology Authors: Thomas Ming Swi Chang Source Type: research

Identification of candidate blood biomarkers for the diagnosis of septicaemic melioidosis based on WGCNA
Volume 50, Issue 1, December 2022, Page 252-259 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 3, 2022 Category: Biotechnology Authors: Li Yin Yuanyuan Chen Tingting Fu Lin Liu Qianfeng Xia Source Type: research

Expression of Concern
Volume 50, Issue 1, December 2022, Page 221-221 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 28, 2022 Category: Biotechnology Source Type: research

Expression of Concern
Volume 50, Issue 1, December 2022, Page 227-227 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 27, 2022 Category: Biotechnology Source Type: research

Statement of Retraction
Volume 50, Issue 1, December 2022, Page 226-226 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 27, 2022 Category: Biotechnology Source Type: research

Statement of Retraction
Volume 50, Issue 1, December 2022, Page 225-225 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 27, 2022 Category: Biotechnology Source Type: research

Statement of Retraction
Volume 50, Issue 1, December 2022, Page 224-224 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 27, 2022 Category: Biotechnology Source Type: research

Expression of Concern
Volume 50, Issue 1, December 2022, Page 223-223 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 27, 2022 Category: Biotechnology Source Type: research

Expression of Concern
Volume 50, Issue 1, December 2022, Page 222-222 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - July 27, 2022 Category: Biotechnology Source Type: research